ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0164

Online Patient Survey on the Impact of Extreme Weather Events on Autoimmune and Rheumatic Diseases

Iazsmin Ventura1, Tamiko Katsumoto2, Natasha Powell3, Elena Adams4 and Olivia Casey5, 1Section of Rheumatology, University of Chicago, Chicago, 2Division of Immunology and Rheumatology, Stanford University, Millbrae, CA, 3University of Chicago Pritzker School of Medicine, Chicago, 4New Rochelle High School, New Rochelle, 5Autoimmune Association, Eastpointe

Meeting: ACR Convergence 2025

Keywords: Climate Change, Epidemiology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0145–0174) Epidemiology & Public Health Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: The impact of climate change on autoimmune and rheumatic diseases remains poorly understood. However, emerging evidence suggests extreme weather events, often related to climate change, may be associated with disease flares, hospitalizations, and disruptions in access to medical care. This pilot study, the first retrospective online survey of its kind, investigates associations between extreme weather events, patient demographics, and self-reported disease flares.

Methods: An online survey was distributed to U.S. individuals with autoimmune and rheumatic diseases, collecting data on demographics, diagnoses, self-reported flares, and exposure to extreme weather events (e.g., floods, wildfires). It also assessed healthcare utilization, treatment disruptions, mental health impacts, and barriers to medical access post-extreme weather. Respondents were grouped based on whether their disease flare occurred within 90 days of their most severe extreme weather event or not. Chi-square analyses examined associations between flares, demographics, weather events, and healthcare access.

Results: Among 155 participants, 88 participants (57%) reported having a disease flare within the period investigated. Participants with polymyalgia rheumatica (50% vs. 10.5%, p = 0.004) and rheumatoid arthritis (24% vs. 9.8%, p = 0.045), were more likely to experience flares within 90 days of their most severe extreme weather event exposure when compared with individuals who did not have the specified disease. Conversely, those with Raynaud’s phenomenon (2.7% vs. 14.9%, p = 0.046) and Sjogren’s disease (2.8% vs 14.8%, p = 0.052) were less likely to experience a flare within 90 days of their most severe extreme weather event. Additionally, participants who were unable to store medication safely (75% vs. 10.4%, p < 0.001) or who had trouble remembering key details of the event (60% vs. 20.8%, p = 0.044) following their most severe extreme weather event were more likely to experience flares within 90 days of this event compared to individuals who did not have those characteristics. Finally, participants who identified as Black (33.3% vs. 10.3%, p = 0.018) were more likely to experience flares within 90 days of their most severe extreme weather event compared to individuals who did not identify as Black.

Conclusion: Difficulty storing medication, specific diseases (polymyalgia rheumatica, rheumatoid arthritis), and identifying as Black were associated with increased flare risk within 90 days following extreme weather events. These findings point to possible mechanisms—like improper medication storage—and reinforce evidence that climate change disproportionately affects vulnerable populations, including racial and ethnic minorities. This exploratory project lays the foundation for future research and education aimed at improving patient resilience to climate change. Next steps include developing a shorter survey focused on the timing and location of severe weather events and flares, and expanding survey dissemination in the U.S. and internationally to better understand the link between severe weather and autoimmune disease flares.


Disclosures: I. Ventura: None; T. Katsumoto: Beyond Meat, 12, Unrestricted grant, Sanofi, 5; N. Powell: None; E. Adams: None; O. Casey: None.

To cite this abstract in AMA style:

Ventura I, Katsumoto T, Powell N, Adams E, Casey O. Online Patient Survey on the Impact of Extreme Weather Events on Autoimmune and Rheumatic Diseases [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/online-patient-survey-on-the-impact-of-extreme-weather-events-on-autoimmune-and-rheumatic-diseases/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/online-patient-survey-on-the-impact-of-extreme-weather-events-on-autoimmune-and-rheumatic-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology